Home › Free Stock Grades › LXRX
Lexicon Pharmaceuticals, Inc. (LXRX) Stock Grade
LXRX · Healthcare
C
Market Cap
$844.0M
P/E Ratio
—
Revenue Growth (YoY)
+60.2%
Net Margin
-101.1%
Return on Equity
—
Dividend Yield
None
About Lexicon Pharmaceuticals, Inc.'s fundamentals
Lexicon Pharmaceuticals is a biotech company with a market capitalization of $844.0 million that demonstrated strong revenue growth of 60.2% year-over-year, indicating expanding commercial operations or product sales. However, the company is currently unprofitable, operating with a net margin of -101.1% and reporting a net loss in its latest annual statement, which is not uncommon for biotechnology firms in growth or development phases. The company does not pay a dividend, which is typical for loss-making businesses reinvesting capital into research and development or commercialization efforts.